Interleukin-1 β accelerates the onset of stroke in stroke-prone spontaneously hypertensive rats

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Chiba, Tsuyoshi ^a   Itoh, Tatsuki ^b   Tabuchi, Masaki ^b   Nakazawa, Toru ^c   Satou, Takao ^b,d  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d KINDAI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; INCIDENCE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; HYPERTENSION; ORGAN SIZE; WISTAR KYOTO RAT;

RATTUS;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; HYPERTENSION; INFLAMMATION; INTERLEUKIN-1BETA; MALE; ORGAN SIZE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STROKE;

MLCS; MLOWN;

EID: 84872812639     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/701976     Document Type: Article

References (33)

1. Blake G. J., Ridker P. M., Inflammatory bio-markers and cardiovascular risk prediction. Journal of Internal Medicine 2002 252 4 283 294 2-s2.0-0036035527 10.1046/j.1365-2796.2002.01019.x (Pubitemid 35253696)
2. Sánchez-Moreno C., Dashe J. F., Scott T., Thaler D., Folstein M. F., Martin A., Decreased levels of plasma Vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004 35 1 163 168 2-s2.0-0347356516 10.1161/01.STR.0000105391.62306.2E (Pubitemid 38057613)
3. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., Petrek M., Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators of Inflammation 2005 2005 3 175 179 2-s2.0-25644437697 10.1155/MI.2005.175 (Pubitemid 41381527)
4. Madej A., Okopień B., Kowalski J., Haberka M., Herman Z. S., Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Pharmacological Reports 2005 57 6 878 881 2-s2.0-33645679314
5. Lindsberg P. J., Grau A. J., Inflammation and infections as risk factors for ischemic stroke. Stroke 2003 34 10 2518 2532 2-s2.0-0141865574 10.1161/01.STR.0000089015.51603.CC (Pubitemid 37221976)
6. Ridker P. M., Danielson E., Fonseca F. A. H., Genest J., Gotto A. M., Kastelein J. J. P., Koenig W., Libby P., Lorenzatti A. J., MacFadyen J. G., Nordestgaard B. G., Shepherd J., Willerson J. T., Glynn R. J., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine 2008 359 21 2195 2207 2-s2.0-56749106312 10.1056/NEJMoa0807646
7. Okamoto K., Yamori Y., Nagaoka A., Establishment of the stroke prone spontaneously hypertensive rat (SHR). Circulation Research 1974 34 1 143 153 2-s2.0-0016222572
8. Sironi L., Gianazza E., Gelosa P., Guerrini U., Nobili E., Gianella A., Cremonesi B., Paoletti R., Tremoli E., Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 3 598 603 2-s2.0-14644432487 10.1161/01.ATV.0000157145.98200.55 (Pubitemid 40315684)
9. Nakamura T., Yamamoto E., Kataoka K., Yamashita T., Tokutomi Y., Dong Y. F., Matsuba S., Ogawa H., Kim-Mitsuyama S., Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 2007 38 11 3016 3022 2-s2.0-35748980879 10.1161/STROKEAHA.107.486522 (Pubitemid 350041562)
10. Ishizuka T., Niwa A., Tabuchi M., Ooshima K., Higashino H., Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats. Life Sciences 2008 82 13-14 806 815 2-s2.0-40649106179 10.1016/j.lfs.2008.01.017
11. Tymianski M., Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011 42 11 3003 3004 10.1161/STROKEAHA.111. 626762
12. Chiba T., Ezaki O., Dietary restriction suppresses inflammation and delays the onset of stroke in stroke-prone spontaneously hypertensive rats. Biochemical and Biophysical Research Communications 2010 399 1 98 103 2-s2.0-77955570393 10.1016/j.bbrc.2010.07.048
13. Giulian D., Woodward J., Young D. G., Krebs J. F., Lachman L. B., Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. Journal of Neuroscience 1988 8 7 2485 2490 2-s2.0-0023772364
14. Quagliarello V. J., Wispelwey B., Long W. J., Scheld W. M., Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat: characterization and comparison with tumor necrosis factor. Journal of Clinical Investigation 1991 87 4 1360 1366 2-s2.0-0025910921
15. Denes A., Pinteaux E., Rothwell N. J., Allan S. M., Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target. Cerebrovascular Diseases 2011 32 6 517 527 10.1159/000332205
16. Chiba T., Itoh T., Tabuchi M., Satou T., Ezaki O., Dietary protein, but not carbohydrate, is a primary determinant of the onset of stroke in stroke-prone spontaneously hypertensive rats. Stroke 2009 40 8 2828 2835 2-s2.0-68749094110 10.1161/STROKEAHA.109.555383
17. Amarenco P., Labreuche J., Lavallée P., Touboul P. J., Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004 35 12 2902 2909 2-s2.0-9444249842 10.1161/01.STR.0000147965.52712.fa (Pubitemid 39565192)
18. Liao J. K., Beyond lipid lowering: the role of statins in vascular protection. International Journal of Cardiology 2002 86 1 5 18 2-s2.0-0036829777 10.1016/S0167-5273(02)00195-X (Pubitemid 35247880)
19. Vaughan C. J., Prevention of stroke and dementia with statins: effects beyond lipid lowering. American Journal of Cardiology A 2003 91 4 23B 29B 2-s2.0-0037456569 10.1016/S0002-9149(02)03270-8 (Pubitemid 36263245)
20. Vergouwen M. D. I., De Haan R. J., Vermeulen M., Roos Y. B. W. E. M., Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008 39 2 497 502 2-s2.0-39349084356 10.1161/STROKEAHA.107.488791 (Pubitemid 351619482)
21. Puddey I. B., Low serum cholesterol and the risk of cerebral haemorrhage. Atherosclerosis 1996 119 1 1 6 2-s2.0-0030050630 10.1016/0021-9150(95)05634-3 (Pubitemid 26018752)
22. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S., The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta 2011 1813 5 878 888 2-s2.0-79955650634 10.1016/j.bbamcr.2011.01. 034
23. Shohami E., Ginis I., Hallenbeck J. M., Dual role of tumor necrosis factor alpha in brain injury. Cytokine and Growth Factor Reviews 1999 10 2 119 130 2-s2.0-0032830106 10.1016/S1359-6101(99)00008-8 (Pubitemid 29446376)
24. Shaftel S. S., Carlson T. J., Olschowka J. A., Kyrkanides S., Matousek S. B., O'Banion M. K., Chronic interleukin-1 β expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood-brain barrier permeability without overt neurodegeneration. Journal of Neuroscience 2007 27 35 9301 9309 2-s2.0-34548434392 10.1523/JNEUROSCI.1418-07.2007 (Pubitemid 47358197)
25. Boutin H., LeFeuvre R. A., Horai R., Asano M., Iwakura Y., Rothwell N. J., Role of IL-1 and IL-1 β in ischemic brain damage. Journal of Neuroscience 2001 21 15 5528 5534 2-s2.0-0035413361 (Pubitemid 32692151)
26. Banwell V., Sena E. S., Macleod M. R., Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. Journal of Stroke and Cerebrovascular Diseases 2009 18 4 269 276 2-s2.0-67649117904 10.1016/j.jstrokecerebrovasdis.2008.11.009
27. Emsley H. C. A., Smith C. J., Georgiou R. F., Vail A., Hopkins S. J., Rothwell N. J., Tyrrell P. J., A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 10 1366 1372 2-s2.0-25444517949 10.1136/jnnp.2004.054882 (Pubitemid 41360973)
28. Rezaii A. A., Hoseinipanah S. M., Hajilooi M., Rafiei A. R., Shikh N., Haidari M., Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. Immunological Investigations 2009 38 3-4 220 230 2-s2.0-70350635584 10.1080/08820130902766142
29. Skinner R. A., Gibson R. M., Rothwell N. J., Pinteaux E., Penny J. I., Transport of interleukin-1 across cerebromicrovascular endothelial cells. British Journal of Pharmacology 2009 156 7 1115 1123 2-s2.0-67650674339 10.1111/j.1476-5381.2008.00129.x
30. Harari O. A., Liao J. K., NF- B and innate immunity in ischemic stroke. Annals of the New York Academy of Sciences 2010 1207 32 40 2-s2.0-78149259667 10.1111/j.1749-6632.2010.05735.x
31. Wu H., Zhang Z., Hu X., Zhao R., Song Y., Ban X., Qi J., Wang J., Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: a postmortem study. Brain Research 2010 1342 111 117 2-s2.0-77953286758 10.1016/j.brainres.2010.04.033
32. Pate M., Damarla V., Chi D. S., Negi S., Krishnaswamy G., Endothelial cell biology. Role in the inflammatory response. Advances in Clinical Chemistry 2010 52 C 109 130 2-s2.0-77957007533 10.1016/S0065-2423(10)52004-3
33. Goldstein L. B., Bushnell C. D., Adams R. J., Appel L. J., Braun L. T., Chaturvedi S., Creager M. A., Culebras A., Eckel R. H., Hart R. G., Hinchey J. A., Howard V. J., Jauch E. C., Levine S. R., Meschia J. F., Moore W. S., Nixon J. V., Pearson T. A., Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 42 2 517 584 10.1161/STR.0b013e3181fcb238